ABT — Abbott Laboratories Share News
0.000.00%
Last trade - 00:00- $190.39bn
- $217.85bn
- $44.33bn
FDA approves Freenome's blood test for colorectal cancer screening (updated)
FDA approves Freenome's blood test for colorectal cancer screening
Factbox: US companies face rise in cyber attacks
Brief: FDA Approves Freenome’S Simplescreen™ Crc Blood-Based Screening Test Abbott To Commercialize In The U.S.
Abbott defeats shareholder lawsuit over 2022 infant formula recall (updated)
Abbott wins dismissal of shareholder lawsuit over 2022 infant formula recall
Abbott investigates two separate cyber incidents, says no operations affected (updated)
Factbox: US companies face rise in cyber attacks
Abbott investigates two separate cyber incidents, says no operations affected
Intuitive Surgical falls as Obamacare concerns rekindle medtech demand debate (updated)
Intuitive Surgical falls as Obamacare concerns rekindle medtech demand debate
U.S. RESEARCH ROUNDUP-IBM, MSCI, US Bancorp
US STOCKS-Wall Street ends lower as chip weakness offsets solid earnings, economic data
US STOCKS-Wall Street ends lower as chip weakness offsets solid earnings, economic data
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
US STOCKS-Chip selloff drags Wall Street lower, offsetting solid earnings, economic data
U.S. STOCKS ON THE MOVE-Citizens Financial, ManpowerGroup, Distribution Solutions
US STOCKS-S&P 500, Nasdaq fall as chips extend losses; earnings and data in focus
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT